ANCA-positive crescentic glomerulonephritis in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor alpha

被引：6
|
作者：
Alkhunaizi, Ahmed M. [1 ]
Dawamneh, Mohamad F. [2 ]
机构：
[1] Johns Hopkins Aramco Healthcare, Internal Med Serv Div, Nephrol Sect, Dhahran, Saudi Arabia
[2] Johns Hopkins Aramco Healthcare, Div Pathol, Dhahran, Saudi Arabia
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2017年 / 20卷 / 11期
关键词：
HENOCH-SCHONLEIN PURPURA; RECEIVING TREATMENT; RENAL VASCULITIS; ETANERCEPT; THERAPY;
D O I：
10.1111/1756-185X.12612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1843 / 1847
页数：5
相关论文
共 50 条
  • [1] Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis
    Haerter, G
    Manfras, BJ
    de Jong-Hesse, Y
    Wilts, H
    Mertens, T
    Kern, P
    Schmitt, M
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : E88 - E94
  • [2] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    [J]. ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [3] Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor
    Zamarrón, C
    Maceiras, F
    González, J
    Gómez-Reino, JJ
    [J]. RESPIRATORY MEDICINE, 2004, 98 (02) : 123 - 125
  • [4] Pseudotumoral neurobehcet in a patient treated with anti-tumor necrosis factor alpha
    Martinez-Estupinan, Lina
    Javier Lopez-Longo, Francisco
    Monteagudo, Indalecio
    Carreno Perez, Luis
    [J]. MEDICINA CLINICA, 2015, 144 (05): : 235 - 236
  • [5] Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
    Daniel, Rodney S.
    Bourne, Rae L.
    Simpson, Annie N.
    O'Rourke, Kenneth S.
    Bolster, Marcy B.
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2009, 1 (02) : 81 - 89
  • [6] Anti-Tumor Necrosis Factor-alpha Therapy Provokes Latent Leishmaniasis in a Patient with Rheumatoid Arthritis
    Franklin, Gillian
    Greenspan, Joel
    Chen, Sheng
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2009, 39 (02): : 192 - 195
  • [7] Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action
    Feldmann, M
    Brennan, F
    Paleolog, E
    Taylor, P
    Maini, RN
    [J]. EUROPEAN CYTOKINE NETWORK, 1997, 8 (03) : 297 - 300
  • [8] Prolonged Remission of Marginal Zone Lymphoma in a Patient with Rheumatoid Arthritis Treated with Anti-tumor Necrosis Factor Agents
    Donaldson, Sarah L.
    Owen, Roger G.
    Mcgonagle, Dennis G.
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (12)
  • [9] Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha
    Richez, C.
    Blanco, P.
    Gin, H.
    Schaeverbeke, T.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : 607 - 607
  • [10] Risk of Serious Infection and Malignancy in Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Biologics
    Thyagarajan, Veena
    Norman, Heather
    Enger, Cheryl
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 160 - 160
12345